M. Thomas et al., Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation, J BIOL CHEM, 275(51), 2000, pp. 40235-40243
Myostatin, a member of the transforming growth factor-beta (TGF-beta) super
family, has been shown to be a negative regulator of myogenesis. Here we sh
ow that myostatin functions by controlling the proliferation of muscle prec
ursor cells. When C2C12 myoblasts were incubated with myostatin, proliferat
ion of myoblasts decreased with increasing levels of myostatin. Fluorescenc
e-activated cell sorting analysis revealed that myostatin prevented the pro
gression of myoblasts from the G(1)- to S-phase of the cell cycle. Western
analysis indicated that myostatin specifically up-regulated p21(Waf1,Cip1).
a cyclin-dependent kinase inhibitor, and decreased the levels and activity
of Cdk2 protein in myoblasts, Furthermore, we also observed that in myoblas
ts treated with myostatin protein, Rb was predominately present in the hypo
phosphorylated form. These results suggests that, in response to myostatin
signaling, there is an increase in p21 expression and a decrease in Cdk2 pr
otein and activity thus resulting in an accumulation of hypophosphorylated
Rb protein. This, in turn, leads to the arrest of myoblasts in G(1)-phase o
f cell cycle, Thus, we propose that the generalized muscular hyperplasia ph
enotype observed in animals that lack functional myostatin could be as a re
sult of deregulated myoblast proliferation.